News
-
Fast Track Validation Programme – eight Projects selected
EP PerMed is pleased to announce the selection of eight outstanding projects for its Fast Track Validation Programme, an initiative designed to accelerate the development, validation, and adoption of innovative personalised medicine solutions across Europe.
-
Showcasing Impactful Research in Personalised Medicine: The PRETWINSCREEN project
EP PerMed has published its second success story, showcasing impactful research and collaborations in personalised medicine. The PRETWINSCREEN project developed new, tailored screening tools to improve the early detection of complications and personalise care in twin pregnancies, helping clinicians to better protect both mothers and babies.
-
EP PerMed Survey on the ‘Awareness of Citizens of Personalised Medicine’
The EP PerMed Survey on the ‘Awareness of Citizens of Personalised Medicine’ aims to generate data on people’s awareness and perception of personalised medicine, and to develop a strategy to increase awareness and participation within a wider international community. You can help us by filling out the survey and forwarding it to your friends and colleagues.
-
Vote Now! EP PerMed “The Story Behind Our Personalised Medicine Research Project” Video Competition 2025
We’re excited to launch the public voting phase for the EP PerMed video competition for ERA PerMed JTC2022 funded projects! Young researchers have shared the innovative research projects they are participating in shaping the future of personalised medicine.
EP PerMed NSC2025
Networking opportunity for previously funded projects in personalised medicine
Financial support (up to 30.000 euro) for researchers from previously funded projects in ERA PerMed and EP PerMed to organise a networking event (workshop or conference) addressing translational issues in personalised medicine!
Citizen Awareness of Personalised Medicine
Your opinion matters!
Have you been involved in a personalised treatment or are you aware of personalised medicine approaches?
EP PerMed likes to understand how well people are informed about personalised medicine, how they perceive it, and their thoughts on its potential benefits and challenges.
The anonymous survey contains 36 questions and takes approximately 10-15 minutes to complete. It is currently available in: English, Czech, Danish, Finnish, French, German, Greek, Italian, Norwegian, Dutch, Polish, Portuguese, Romanian, Spanish, Swedish and Turkish.
Mission & Objectives
Governance & Boards
The European Partnership for Personalised Medicine gathers together around 60 partners from 25 countries. The Consortium is managed by a so-called Coordination Unit (CU) and General Assembly (GeA). The day-to-day business, planning and implementation of activities is realized through five Work Packages. The EP PerMed overarching Advisory Bodies are ICPerMed, an Advisory Board and a Stakeholder Forum.